Showing 321-330 of 1145 results for "".
Practical Advice for Defining Your Brand on Social Media
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-may-video-2024/37344/Joseph J. Allen, OD, FAAO, Dipl ABO, is host to several successful online channels in addition to Eye Care Insiders, and in this episode, he offers seven tips for creating or jumpstarting a practice’s social media presence. Drawing on years of experience with creating content for various audiences,The Rundown on Vevye
https://modernod.com/videos/eye-care-insiders/the-rundown-on-vevye/37342/Joseph J. Allen, OD, FAAO, Dipl ABO, goes over what you need to know about the recently FDA-approved, nonpreserved cyclosporine ophthalmic solution 0.1% (Vevye, Novaliq) for treating the signs and symptoms of dry eye disease. He discusses what makes the drop unique compared with other cyclosporine pA Year of Growth and Gratitude
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-dec-2023-video/37337/For this last episode of Eye Care Insiders in the year 2023, Joseph J. Allen, OD, FAAO, Dipl ABO, looks back on the changes this past year has brought to his professional life as both a clinician and content creator, from FDA approvals of new optometric products, to increased opportunities to presenA Basic Guide to Fitting Multifocal Contact Lenses
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-february-2025-video/37353/Joseph J. Allen, OD, FAAO, Dipl ABO, offers his insights for fitting multifocal lenses in this episode of Eye Care Insiders. He talks about various multifocal lenses available, discussing unique aspects of their designs and fitting guides that are important to keep in mind to achieve the optimal fitLLLT and AMD: Your Questions Answered
https://modernod.com/topics/retina/lllt-and-amd-your-questions-answered/37350/Joseph J. Allen, OD, FAAO, Dipl ABO, gives an overview of a recently FDA-authorized low-level light therapy, or photobiomodulation, device, the Valeda Light Delivery System (LumiThera). He explains the device’s unique mechanism of action for treating age-related macular degeneration, reviews promisiWhat’s Hot in Heat Therapy for OSD
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-oct-2024-video/37349/Joseph J. Allen, OD, FAAO, Dipl ABO, takes a look at the plethora of options available for treating ocular surface disease with a warm compress. He offers important reminders to share with patients, reviews recent data to back up your recommendations, and groups the products into different categorieLLLT: Not Just for Dry Eye
https://modernod.com/videos/eye-care-insiders/lllt-not-just-for-dry-eye/37347/Joseph J. Allen, OD, FAAO, Dipl ABO, discusses low-level light therapy (LLLT), which has been used in the treatment of dry eye, as a potential use for the management of myopia. He explains how LLLT, aka red light therapy, works to achieve a therapeutic benefit through photobiomodulation, provides aPrioritizing Ocular Wellness and Hygiene
https://modernod.com/videos/eye-care-insiders/eci-april-2024-video/37343/Joseph J. Allen, OD, FAAO, Dipl ABO, describes a trend in eye care that models routine exams after those that take place in dentistry (ie, beginning the eye exam with an ocular surface cleansing procedure, then educating patients on everyday ocular wellness and hygiene practices, before performing tAI and Eye Care
https://modernod.com/videos/eye-care-insiders/ai-and-eye-care/37341/The age of AI is here. How might this technology be helpful to the optometric profession? Joseph J. Allen, OD, FAAO, Dipl ABO, reviews what research has shown regarding the accuracy of AI in identifying and tracking the progression of various ocular conditions. He also considers other areas where AIFinally, a Treatment for Demodex Blepharitis
https://modernod.com/videos/eye-care-insiders/sl-are-you-prepared-to-treat-demodex-blepharitis-ph-heres-what-you-need-to-know-about-the-first-fda-approved-treatment-title-finally-a-treatment-for-demodex-blepharitis-the-first-fda-approved-treatment-for-idemodex-blepharitisi/37330/The first FDA-approved treatment for Demodex blepharitis has arrived, and Joseph J. Allen, OD, FAAO, Dipl ABO, reviews what you need to know to start using it in your clinic. He discusses the novel mechanism of action of lotilaner ophthalmic solution 0.25% (Xdemvy, formerly TP-03; Tarsus Pharmaceuti